Key result
In CAPD patients, a target plasma hANP level of 40-50 pg/ml is proposed to assess optimal circulating blood volume and protect against hypertrophic cardiomyopathy by preventing preload.
Why the study?
Does plasma hANP level serve as a useful marker for optimal circulating blood volume to prevent left ventricular hypertrophy in CAPD patients?
Observational (n=53)
Yes
Does plasma hANP level serve as a useful marker for optimal circulating blood volume to prevent left ventricular hypertrophy in CAPD patients?
Plasma hANP is a more sensitive marker than CTR for detecting mild left ventricular hypertrophy in CAPD patients, with a proposed target level of 40-50 pg/ml to prevent volume overload and LVH progression.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shiota et al. (1998) conducted an observational in Continuous Ambulatory Peritoneal Dialysis (CAPD) (n=53). Plasma atrial natriuretic peptide (hANP) level was evaluated on Plasma hANP levels across groups with varying degrees of left ventricular hypertrophy. In CAPD patients, a target plasma hANP level of 40-50 pg/ml is proposed to assess optimal circulating blood volume and protect against hypertrophic cardiomyopathy by preventing preload.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: